Webster Brian Daniel 4
4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Kestra Medical Technologies CEO Brian Webster Sells 15,000 Shares
What Happened
Brian D. Webster, President and Chief Executive Officer of Kestra Medical Technologies (KMTS), sold 15,000 shares in an open-market/ private sale on June 15, 2026. The reported weighted-average sale price was $20.81 per share, producing proceeds of approximately $312,143. This was a sale (S), which is often routine rather than a bullish signal.
Key Details
- Transaction date: 2026-06-15 (reported on Form 4 filed 2026-06-17) — filing appears timely.
- Transaction type/code: Sale (S) — open market or private sale.
- Shares sold: 15,000; weighted-average price: $20.81; total proceeds: ~$312,143.
- Price range: shares were sold at prices between $20.54 and $21.39 (weighted average shown).
- Footnotes: Transaction occurred pursuant to a Rule 10b5-1 trading plan adopted 2025-09-29. The filer notes the weighted average and offers to provide breakdown by price on request.
- Shares owned after transaction: Not disclosed in the information provided.
Context
Sales made under an established 10b5-1 plan are pre-arranged and are commonly used by insiders to sell shares on a scheduled basis; such sales do not necessarily reflect current views on the company's prospects. This report shows a routine insider sale rather than a purchase or exercise.
Insider Transaction Report
- Sale
Common Shares
[F1][F2]2026-06-15$20.81/sh−15,000$312,143→ 395,467 total
Footnotes (2)
- [F1]The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
- [F2]The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.5400 to $21.3900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.